Clinical Trial Update: An Efficacy and Safety Study w/ Azstarys® in Children 4-12 Years of Age With ADHD [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the efficacy and safety of Azstarys in children aged 4-12 with Attention Deficit/Hyperactivity Disorder has completed, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Azstarys (serdexmethylphenidate/dexmethylphenidate)

Snippet

Sponsor: Corium, Inc. | Conditions: Attention Deficit/Hyperactivity Disorder | Phase 4 | Status: COMPLETED | Results posted: 2025-05-13